Dr. Joseph Nkuranga
Scientific Coordinator
Quick Facts
Dr. Joseph Nkuranga is a clinical trialist with extensive experience in HIV care and support and program management. He is a Study Coordinator and Project Director at the Centre for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi where he has coordinated two clinical trials and other clinical studies. He also directs the CDC-funded Monitor and Prevent Antimicrobial Resistance project at the university. Prior to this, he was a technical advisor in PEPFAR-funded HIV service delivery projects across Kenya for 10 years. He holds a Bachelor degree in Medicine and Surgery (MBChB) from the University of Nairobi, Post-graduate Diploma of the London School of Hygiene and Tropical Medicine in Epidemiology, and a Master of Science in Epidemiology from the University of London.
Publications
Showing 1-4 of 4 publications
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial
High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.
Penner Jeremy, Ombajo Loice A, Nkuranga Joseph, Otieno Edwin, Nyakoe Diana, Wanjohi Ruth, Mbewa Victor, Ndinya Florentius, Eshiwani Sheila, Wahome Simon, Bhagani Sanjay, Pozniak Anton, Gregson Celia L. "High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.". HIV medicine. (2025 Mar)
HIV medicine • 2024-11-21T00:00:00.000Z
Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
Ombajo Loice A, Penner Jeremy, Nkuranga Joseph, Mecha Jared, Mburu Margaret, Odhiambo Collins, Ndinya Florentius, Aksam Rukia, Njenga Richard, Wahome Simon, Muiruri Peter, Eshiwani Sheila, Kimani Maureen, Ngugi Catherine, Pozniak Anton. "Second-Line Switch to Dolutegravir for Treatment of HIV Infection.". The New England journal of medicine. (2023 Jun 22)
The New England journal of medicine • 2023-06-22T00:00:00.000Z
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.
Penner Jeremy, Ombajo Loice Achieng, Otieno Davies, Nkuranga Joseph, Mburu Margaret, Wahome Simon, Pozniak Anton, Bhagani Sanjay. "High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.". PloS one. (2023)
PloS one • 2023-01-01T00:00:00.000Z
